NCT06775522View on ClinicalTrials.gov

Bioequivalence (BE) Study Between YHP2205 and YHR2401 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 11, 2025

Primary Completion Date

January 20, 2025

Study Completion Date

January 21, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

YHP2205

Test drug: YHP2205 Comparator: YHR2401

DRUG

YHR2401

Test drug: YHP2205 Comparator: YHR2401

Trial Locations (1)

07590

Bumin Hospital, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT06775522 - Bioequivalence (BE) Study Between YHP2205 and YHR2401 in Healthy Volunteers | Biotech Hunter | Biotech Hunter